138 related articles for article (PubMed ID: 1311786)
1. [Possible mechanisms for (H+ + K+)-ATPase inhibition by proton pump inhibitors, omeprazole, lansoprazole and SCH 28080].
Nagaya H; Satoh H
Nihon Rinsho; 1992 Jan; 50(1):26-32. PubMed ID: 1311786
[TBL] [Abstract][Full Text] [Related]
2. [Discovery and development of the proton pump inhibitor].
Igata H; Okabe S
Nihon Rinsho; 1992 Jan; 50(1):11-7. PubMed ID: 1311779
[TBL] [Abstract][Full Text] [Related]
3. The H+, K(+)-ATPase inhibitor pantoprazole (BY1023/SK&F96022) interacts less with cytochrome P450 than omeprazole and lansoprazole.
Simon WA; Büdingen C; Fahr S; Kinder B; Koske M
Biochem Pharmacol; 1991 Jul; 42(2):347-55. PubMed ID: 1650212
[TBL] [Abstract][Full Text] [Related]
4. Effects of the enantiomers of lansoprazole (AG-1749) on (H+ + K+)-ATPase activity in canine gastric microsomes and acid formation in isolated canine parietal cells.
Nagaya H; Inatomi N; Nohara A; Satoh H
Biochem Pharmacol; 1991 Oct; 42(10):1875-8. PubMed ID: 1660270
[TBL] [Abstract][Full Text] [Related]
5. [Proton pump inhibitors: their merits and demerits, and perspectives for future investigation].
Kamada T; Kawano S; Tsuji S
Nihon Rinsho; 1992 Jan; 50(1):53-9. PubMed ID: 1347330
[TBL] [Abstract][Full Text] [Related]
6. Possible mechanism for the inhibition of gastric (H+ + K+)-adenosine triphosphatase by the proton pump inhibitor AG-1749.
Nagaya H; Satoh H; Kubo K; Maki Y
J Pharmacol Exp Ther; 1989 Feb; 248(2):799-805. PubMed ID: 2537417
[TBL] [Abstract][Full Text] [Related]
7. Proton-pump inhibition for acid-related disease.
Holt S
South Med J; 1991 Sep; 84(9):1078-87. PubMed ID: 1653998
[TBL] [Abstract][Full Text] [Related]
8. [Proton pump inhibitors in the treatment of peptic ulcers resistant to H2-receptor antagonists].
Asaka M; Kato M; Sato Y; Miyazaki T
Nihon Rinsho; 1992 Jan; 50(1):104-10. PubMed ID: 1347322
[TBL] [Abstract][Full Text] [Related]
9. [Studies on the intracellular pharmacodynamic properties of proton pump inhibitors and the inhibitory mechanism of acid secretion].
Saito E; Matsuo Y
Nihon Rinsho; 1992 Jan; 50(1):18-25. PubMed ID: 1311783
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of gastric (H+ + K+)-ATPase by the substituted benzimidazole, picoprazole.
Wallmark B; Sachs G; Mardh S; Fellenius E
Biochim Biophys Acta; 1983 Feb; 728(1):31-8. PubMed ID: 6299338
[TBL] [Abstract][Full Text] [Related]
11. [Changes in the rat stomach after long-term administration of proton pump inhibitors (AG-1749 and E-3810)].
Kawai T; Ikeda H; Harada Y; Saitou T
Nihon Rinsho; 1992 Jan; 50(1):188-93. PubMed ID: 1311785
[TBL] [Abstract][Full Text] [Related]
12. [Characteristic features of proton pump inhibitors in the inhibition of gastric acid secretion: long-acting and complete inhibition].
Ohe K
Nihon Rinsho; 1992 Jan; 50(1):45-52. PubMed ID: 1311789
[TBL] [Abstract][Full Text] [Related]
13. Omeprazole, SCH 28080 and doxepin differ in their characteristics to inhibit H+/K+-ATPase driven proton accumulation by parietal cell membrane vesicles.
Beil W; Staar U; Schünemann P; Sewing KF
Biochem Pharmacol; 1988 Dec; 37(23):4487-93. PubMed ID: 2849447
[TBL] [Abstract][Full Text] [Related]
14. The gastric H+,K+-ATPase: the site of action of omeprazole.
Sachs G; Wallmark B
Scand J Gastroenterol Suppl; 1989; 166():3-11. PubMed ID: 2557669
[TBL] [Abstract][Full Text] [Related]
15. Biological basis of omeprazole therapy.
Sachs G; Wallmark B
J Gastroenterol Hepatol; 1989; 4 Suppl 2():7-18. PubMed ID: 2562365
[TBL] [Abstract][Full Text] [Related]
16. Gastric acid secretion: activation and inhibition.
Sachs G; Prinz C; Loo D; Bamberg K; Besancon M; Shin JM
Yale J Biol Med; 1994; 67(3-4):81-95. PubMed ID: 7502535
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of the effect of proton pump inhibitors on stomal ulcer].
Yukawa K; Yukawa E
Nihon Rinsho; 1992 Jan; 50(1):138-43. PubMed ID: 1347326
[TBL] [Abstract][Full Text] [Related]
18. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
Satoh H; Inatomi N; Nagaya H; Inada I; Nohara A; Nakamura N; Maki Y
J Pharmacol Exp Ther; 1989 Feb; 248(2):806-15. PubMed ID: 2537418
[TBL] [Abstract][Full Text] [Related]
19. Studies on (H(+)-K+)-ATPase inhibitors of gastric acid secretion. Prodrugs of 2-[(2-pyridinylmethyl)sulfinyl]benzimidazole proton-pump inhibitors.
Sih JC; Im WB; Robert A; Graber DR; Blakeman DP
J Med Chem; 1991 Mar; 34(3):1049-62. PubMed ID: 1848293
[TBL] [Abstract][Full Text] [Related]
20. [Clinical effect of proton pump inhibitors on reflux esophagitis].
Sekiguchi T; Horikoshi T; Nishioka T; Kusano M
Nihon Rinsho; 1992 Jan; 50(1):131-7. PubMed ID: 1311780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
